Lei Jianping on April 10
Beijing Largev Instrument Co., Ltd. (hereinafter referred to as "Largev Instrument") IPO was terminated a few days ago. Longvision Instrument had planned to raise 330 million yuan.
Among them, 140 million yuan will be used for the construction project of medical cone beam CT (Haining) production base, 132 million yuan will be used for the construction project of R&D center, and 50.23 million yuan will be used for the construction project of marketing network.
Annual revenue of 400 million
LargeV Instruments is a company that provides advanced medical imaging products and services, mainly engaged in the research and development, production, sales and service of professional medical imaging equipment, and has formed a series of core technologies around cone beam CT imaging technology.
Cone beam CT is a kind of medical imaging equipment that uses cone beam X-ray and flat panel detector for three-dimensional tomography, which is usually composed of X-ray generator, flat panel detector, rotating rack, computer software and other parts. Its working principle is to scan the X-ray generator and flat panel detector around the patient in a circular orbit driven by a rotating frame to obtain projection data from different angles, and the relevant data are converted into three-dimensional image data through a special cone beam CT reconstruction algorithm, and then through a special image processing software for clinicians to observe and diagnose.
The spatial resolution of cone-beam CT is significantly better than that of traditional spiral CT using sector-beam X-ray and line array detectors, and is especially suitable for imaging hard tissues such as teeth and bones.
According to the prospectus, the revenue of Longis Instrument in 2019, 2020 and 2021 will be 222 million yuan, 215 million yuan and 405 million yuan respectively, the net profit will be 20.45 million yuan, 18.1 million yuan and 64.1889 million yuan respectively, and the net profit after deducting non-profits will be 16.79 million yuan, 10.22 million yuan and 56.7277 million yuan respectively.
Nuctech is a shareholder
Before the IPO, Qian Zhiming, chairman of Longvision Instrument, directly held 33.8% of the company's shares, and at the same time held 3.94% of Haining Hairui's capital contribution as a limited partner, and was the controlling shareholder and actual controller of the company.
Tongfang Nuctech (CS) holds 22.68% of the shares, Hetang Exploration holds 8.19% of the shares, Lijin Technology holds 7.97% of the shares, and Langyao Investment holds 3.3% of the shares.
The executive partner of Ningbo Xinote is Huizhong Tongxin, Huizhong Tongxin is a wholly-owned holding company of Hairui Investment, the executive partner of Haining Hairui and Haining Fudao are both Hairui Investment, and the controlling shareholder of Hairui Investment is Hao Qun, so Hao Qun and Ningbo Xinaote, Haining Hairui and Haining Fudao constitute a concerted action relationship, with a total shareholding ratio of 11.95%.
Wang Yajie, a shareholder of the company, is the executive partner of Lijin Technology, so Wang Yajie and Lijin Technology constitute a concerted action relationship, with a total shareholding ratio of 8.92%.
The executive partner of Mizuki Vision is Mizuki Chuangxin, and the two shareholders form a concerted action relationship, with a total shareholding ratio of 7.06%.
Zhang Wenyu, director and general manager of Longvision Instrument, holds 1.06% of the shares, Wu Hongxin, vice chairman and deputy general manager, holds 1.05%, Wang Yajie, deputy general manager, holds 0.95%, Yu Dongmei, deputy general manager and secretary of the board of directors, holds 0.51%, and Li Jianjun holds 0.3%.
———————————————
Lei Di was founded by Lei Jianping, a media person, if it is reprinted, please indicate the source.